Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > reuters & quantitative report
View:
Post by woundedknee on Jun 01, 2021 2:24pm

reuters & quantitative report

Reuters has one buy and 4 outpreform as of a week ago.

Quantitative reports has a sell on the stock..valuation..negative, quality... negative, growth... negative, street sentiment...positive, price momentum negative.
Comment by Forestview on Jun 01, 2021 2:54pm
Link, WK?
Comment by woundedknee on Jun 01, 2021 3:03pm
I picked this up on Scotia iTrade.
Comment by GameChangerBet on Jun 01, 2021 3:06pm
Yea most brokerage firms will provide such reports as part of the services offered on their platform.
Comment by GameChangerBet on Jun 01, 2021 2:59pm
Those quantatative reports are insignificant in it's entirety, when specifically related to Antibe. It is a statistically generated report, which does not take into account many major factors. It is more relevant to a company that has revenues, growth, an actual ongoing business that can be accurately quantified. Antibe is none of those things at the moment. One announcement of a major deal ...more  
Comment by woundedknee on Jun 01, 2021 3:07pm
Yes, I never use that system when buying a stock, but it was there so I put it up.
Comment by GameChangerBet on Jun 01, 2021 3:09pm
It does definitely provide a lot of statistical details. It's essentially a fact sheet
Comment by YukonJezza on Jun 01, 2021 3:54pm
your not to put things up without consent from the PUPMTARDs
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities